Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Jesús Rodríguez‐Baño(Hospital Universitario Virgen Macarena), María Paz García Butenegro, Rosa de Miguel Buckley, Esther Aznar Muñoz, Elena Trigo Esteban(Hospital La Paz Institute for Health Research), Fátima Brañas Baztán, José Ramón Arribas(Hospital Universitario La Paz), Juan Torres Macho(Hospital General Universitario Gregorio Marañón), Chiara Fanciulli, Gemma Muñiz Nicolás, Pablo Ryan, Juan Berenguer(Instituto de Salud Carlos III), Inmaculada Jarrín(Instituto de Salud Carlos III), Belén Loeches Yagüe, Marta Arsuaga Vicente, Marta Díaz‐Menéndez(Hospital Universitario La Paz), Jordi Carratalà(Instituto de Salud Carlos III), Julio García‐Rodríguez, Ignacio Valero(Instituto de Salud Carlos III), Teresa Aldámiz‐Echevarría(Hospital General Universitario Gregorio Marañón), María Yllescas(Fundación Seimc-Gesida), Luz Martín‐Carbonero, Francisco Tejerina(Instituto de Salud Carlos III), Isabel Gutiérrez, Cristina Díez(Hospital General Universitario Gregorio Marañón), Blanca Pinilla, Jerónimo Pachón(Instituto de Biomedicina de Sevilla), Juan Carlos Ramos Ramos, Margarita Ramírez, Juan González‐García(Hospital Universitario La Paz), Pedro Gil Divasson, Clara Aguirre, Inés Fernández Jiménez, Ana Such Díaz, Elena Álvaro Alonso(Hospital General Universitario Gregorio Marañón), Antonia Sepúlveda Berrocal, María Pilar Toledano Sierra, Patricia González Muñiz, Juan Carlos López, Leire Pérez‐Latorre, Jorge Valencia de la Rosa, Alberto Gato Díez
Clinical Microbiology and Infection
August 26, 2020
10.1016/j.cmi.2020.08.010
Cited by 128

Related Papers

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
|Clinical Microbiology and Infection|2021|1k
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
|New England Journal of Medicine|2006|886
Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
|Clinical Microbiology Reviews|2018|688
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data
|The Lancet Respiratory Medicine|2014|648
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521